Route 92 Medical Full Length 046 Access System
Route 92 Medical, Inc. · Decision date Sep 16, 2026
What did the FDA decide?
Route 92 Medical, Inc. received a substantially equivalent (SESE) decision for the Full Length 046 Access System under 510(k) number K260220, dated 2026-09-16. The FDA record lists the device classification as Catheter, Percutaneous, Neurovasculature, product code QJP, regulation number 870.1250, with Cardiovascular as the regulation medical specialty and Neurology as the review panel. The application was received 01/26/2026 and is a Traditional 510(k); it was not reviewed by a third party, is not a combination product, and no predetermined change control plan was authorized.
SESE means the device was cleared as substantially equivalent to a legally marketed predicate; it is not a PMA approval. The record does not identify the predicate device, the specific components or changes assessed, or the indications for use, so those details remain unknown from this page. The linked summary document was not part of the public information, and no clinical or performance data are reported here.
The applicant address is listed as 155 Bovet Rd., San Mateo, CA 94402, with Kirsten Valley as applicant contact and Denise Aycox as correspondent contact.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Cardiovascular
- Decision date
- Sep 16, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K260220
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Route 92 Medical, Inc.
- Product code
- QJP
- Decision code
- SESE
- Decision date
- Sep 16, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Catheter, Percutaneous, Neurovasculature.
- Applicant
- Route 92 Medical, Inc.
- Product code
- QJP
- FDA device class
- 2
FDA decision timeline
K260220 received
Application receipt date recorded by FDA.
K260220 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code QJP
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
NeuroSheathK261449 | Perfuze, Ltd. | 510(k) clearance | Nov 5, 2026 | FDA |
| Stryker Neurovascular | 510(k) clearance | Oct 9, 2026 | FDA | |
APRO 88 CatheterK261938 | Alembic, LLC | 510(k) clearance | Oct 6, 2026 | FDA |
OAB Delivery CatheterK253422 | Cognition Medical Corp. | 510(k) clearance | Oct 2, 2026 | FDA |
70 NeuGlide CatheterK262277 | Piraeus Medical, Inc. | 510(k) clearance | Sep 4, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Route 92 Medical, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- San Mateo, CA
Sources and methodology
- Original FDA record: K260220
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
